To compare number of healthy household contacts aged less than 5 years developing Tuberculosis disease after receiving treatment with 3 months isoniazid and rifampicin versus 6 months isoniazid
Phase 3
- Registration Number
- CTRI/2023/05/052273
- Lead Sponsor
- Areej bano
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ALL children less than 5 years of age who are household contacts that is living with bacteriologically confirmed pulmonary tuberculosis patients after ruling out tuberculosis disease in them.
Exclusion Criteria
Children in contact with adults having multidrug resistant tuberculosis or extensively drug resistant tuberculosis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Finding the proportion of children less than 5 years of age who are household contacts <br/ ><br>of pulmonary Tuberculosis patients, developing tuberculosis after receiving treatment with 3 months <br/ ><br>isoniazid and rifampicin versus 6 months isoniazid. <br/ ><br>Timepoint: 2 years
- Secondary Outcome Measures
Name Time Method Finding the Non adherence, Adverse drug events and Completion rate in the proportion of children less than 5 years of age who are household contacts of Tuberculosis patient, after receiving treatment for 6 month isoniazid versus 3 month isoniazid and rifampicinTimepoint: 2 years